🇮🇱 Imdelltra (Amg757) in Israel

Imdelltra (Amg757) (TARLATAMAB) regulatory status in Israel.

Marketing authorisation

MOH

  • Marketing authorisation holder: AMGEN INC
  • Status: likely_approved

Imdelltra (Amg757) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Israel

Frequently asked questions

Is Imdelltra (Amg757) approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Imdelltra (Amg757) in Israel?

AMGEN INC holds the Israeli marketing authorisation.